Ignite Creation Date:
2025-12-24 @ 4:51 PM
Ignite Modification Date:
2026-05-30 @ 4:17 PM
Study NCT ID:
NCT05559450
Status:
RECRUITING
Last Update Posted:
2022-09-29
First Post:
2022-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALL
Sponsor:
The First Affiliated Hospital of Soochow University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B-cell Acute Lymphoblastic Leukemia | View |
Keywords: